about
Application of ultrasound microbubble contrast technology in ophthalmic targeted therapy: literature analysis.Gene therapy targeting glaucoma: where are we?Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.Protein kinase Cα downregulation via siRNA-PKCα released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells.Gene Therapy of ABCA4-Associated Diseases.Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina.Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.Let There Be Light: Gene and Cell Therapy for Blindness.Nanoparticle applications in ocular gene therapyNonviral ocular gene therapy: assessment and future directions.Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa.Nanoparticles for retinal gene therapy.Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.Impacts of nanomedicines in ocular pharmacotherapySilencing of P2Y2 receptor delays Ap4A-corneal re-epithelialization process.Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.Examination of barriers and barrier alteration in transscleral iontophoresis.Optimizing Cardiac Delivery of Modified mRNA.
P2860
Q30467907-5313F1DA-78BA-4931-BE51-A708516B25CBQ33763673-F8D3837D-4B4B-411E-8EC5-82E889B95B12Q34982118-26211481-D0B7-410E-9916-BE5458E8E6F5Q35090497-0A31B5BB-8317-41D4-A9ED-C8643912C760Q35663857-195A1DCD-C870-4375-9D90-5FF0B56E6603Q36142464-0C308421-E43B-4244-91BD-9CEB4DC5FFA5Q36147481-1E0B6DF0-4C98-479B-A8A7-315871CFFD98Q36654534-C3D2CBA4-A553-4655-BC42-DE40AB9501B9Q36933896-8C35A827-18FF-4B09-8381-9BA288529A23Q37284890-BEA5DD96-5A17-48B4-92B6-40CD4D415E98Q37711208-AD110730-976D-4483-A9AE-09695DB1CEC5Q37746102-6D1C703F-7B6B-4AAF-A99F-1970BB83DEFCQ38063945-3DA032BD-2C4D-43CE-AC8C-C638264A38C0Q38107200-D21D5830-7710-4064-A1D1-A3ADDFA36074Q39838997-719B410B-D1FE-4D96-94DD-C3C5D68AEE22Q41442716-D2CCC88B-A278-488A-BFFA-8C9291C69426Q41825994-BF8BC363-2A7A-4285-8367-79807FE08517Q41891987-B2D601B1-8F55-4420-8161-52AA500671DAQ50445673-9E63AB93-A778-4445-8BAF-29D8841613BC
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ocular gene therapy: a review of nonviral strategies.
@ast
Ocular gene therapy: a review of nonviral strategies.
@en
type
label
Ocular gene therapy: a review of nonviral strategies.
@ast
Ocular gene therapy: a review of nonviral strategies.
@en
prefLabel
Ocular gene therapy: a review of nonviral strategies.
@ast
Ocular gene therapy: a review of nonviral strategies.
@en
P2093
P1433
P1476
Ocular gene therapy: a review of nonviral strategies
@en
P2093
Charlotte Andrieu-Soler
David BenEzra
Francine Behar-Cohen
Nadia Normand
Riad-Antoine Bejjani
Thérèse de Bizemont
P304
P577
2006-10-30T00:00:00Z